Literature DB >> 6891634

Combination effect of azthreonam with four aminoglycosides on nosocomial gram-positive cocci and non-fermenting gram-negative bacteria.

H M Just, E Phillips, M Bassler, F D Daschner.   

Abstract

The inhibitory combination effect of azthreonam with gentamicin, tobramycin, amikacin and netilmicin respectively against 50 non-fermenting gram-negative rods and 30 gram-positive cocci was compared using the checkerboard agar dilution technique. On average 49.5% of all non-fermenting strains were inhibited by additive, and 48.5% by synergistic azthreonam-aminoglycoside combinations, but only 4.5% of the gram-positive cocci were inhibited by synergistic combinations. No antagonism occurred. No significant differences could be found between the effects of the respective azthreonam-aminoglycoside combinations.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6891634     DOI: 10.1007/bf02019937

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  9 in total

1.  Acinetobacter calcoaceticus: a nosocomial pathogen with an unusual seasonal pattern.

Authors:  H F Retailliau; A W Hightower; R E Dixon; J R Allen
Journal:  J Infect Dis       Date:  1979-03       Impact factor: 5.226

2.  [Hospital-acquired infections in a university health centre: prospective analysis of 39 802 patients (author's transl)].

Authors:  F Daschner
Journal:  Dtsch Med Wochenschr       Date:  1981-01-23       Impact factor: 0.628

3.  In-vitro antibacterial activity of SQ 26,776.

Authors:  R Norrby; K Friberg; S E Holm
Journal:  J Antimicrob Chemother       Date:  1981-12       Impact factor: 5.790

4.  Pharmacokinetics of the monobactam SQ 26,776 after single intravenous doses in healthy subjects.

Authors:  E A Swabb; M A Leitz; F G Pilkiewicz; A A Sugerman
Journal:  J Antimicrob Chemother       Date:  1981-12       Impact factor: 5.790

5.  SQ 26,776: in-vitro antibacterial activity and susceptibility to beta-lactamases.

Authors:  I Phillips; A King; K Shannon; C Warren
Journal:  J Antimicrob Chemother       Date:  1981-12       Impact factor: 5.790

6.  In-vitro activity of monobactam, SQ 26,776, against Gram-negative bacteria.

Authors:  A Percival; E Thomas; C A Hart; P Karayiannis
Journal:  J Antimicrob Chemother       Date:  1981-12       Impact factor: 5.790

7.  SQ 26,776, a novel beta-lactam: an in-vitro comparison with other antimicrobial agents.

Authors:  R Wise; J M Andrews; J Hancox
Journal:  J Antimicrob Chemother       Date:  1981-12       Impact factor: 5.790

8.  In vitro efficacy of Bay k 4999, a new ureido-penicillin, in combination with aminoglycosides against Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae and Proteus strains.

Authors:  F D Daschner; A Steffens; H Langmaack
Journal:  Chemotherapy       Date:  1979       Impact factor: 2.544

9.  Acinetobacter calcoaceticus variety anitratus: an increasing nosocomial problem.

Authors:  R Ramphal; R M Kluge
Journal:  Am J Med Sci       Date:  1979 Jan-Feb       Impact factor: 2.378

  9 in total
  3 in total

1.  Combination effect of SCE-2787 and cefepime with aminoglycosides on nosocomial gram-negative bacteria.

Authors:  J Hübner; D Hartung; A Kropec; F D Daschner
Journal:  Infection       Date:  1991 May-Jun       Impact factor: 3.553

Review 2.  Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  R N Brogden; R C Heel
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546

3.  Combination effect of meropenem with aminoglycosides and teicoplanin on Pseudomonas and enterococci.

Authors:  A Kropec; S Lemmen; M Wursthorn; F D Daschner
Journal:  Infection       Date:  1994 Jul-Aug       Impact factor: 3.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.